Literature DB >> 6831768

Stimulation of murine macrophage cathepsin B by serum from patients with rheumatoid arthritis: an indicator of disease activity.

M Ostensen, B Mørland, G Husby.   

Abstract

Cultures of non-elicited mouse peritoneal macrophages were used as a test system to study the effect of sera from patients with rheumatoid arthritis (RA) on intra-cellular cathepsin B activity of macrophages. Sequential sera obtained during and after pregnancy from six RA patients, and sera from six actively ill, non-pregnant RA patients were compared to six healthy female controls and 3rd trimester healthy women. Sera from actively ill RA patients (both pregnant and non-pregnant) caused macrophage cathepsin B levels significantly above normal controls, while intra-cellular activities of beta-glucuronidase and N-acetyl-glucosaminidase did not differ from the controls. A significant correlation between activity of RA and intracellular cathepsin B was found in pregnant patients. It is suggested that a factor (or factors) present in serum from patients with active RA causes a rise of intracellular cathepsin B in macrophages.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6831768      PMCID: PMC1536763     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  18 in total

1.  Assessment of rheumatoid activity based on clinical features and blood and synovial fluid analysis.

Authors:  M Farr; M J Kendall; D W Young; M J Meynell; C F Hawkins
Journal:  Ann Rheum Dis       Date:  1976-04       Impact factor: 19.103

2.  The assessment of rheumatoid arthritis. A study based on measurements of the serum acute-phase reactants.

Authors:  B McConkey; R A Crockson; A P Crockson
Journal:  Q J Med       Date:  1972-04

3.  Activation of macrophages to produce neutral proteinases by endocytosis of alpha 2-macroglobulin-trypsin complexes.

Authors:  T L Vischer; D Berger
Journal:  J Reticuloendothel Soc       Date:  1980-11

4.  Protease inhibitors in inflammatory synovial effusions.

Authors:  N M Hadler; A M Johnson; J K Spitznagel; R J Quinet
Journal:  Ann Rheum Dis       Date:  1981-02       Impact factor: 19.103

5.  Lysosomal cathepsin B: correlation with metastatic potential.

Authors:  B F Sloane; J R Dunn; K V Honn
Journal:  Science       Date:  1981-06-05       Impact factor: 47.728

6.  Immunopathological mechanisms in rheumatoid arthritis at the dual interface of the synovial membrane: the joint cavity and the pannus.

Authors:  R N Maini
Journal:  Rheumatol Rehabil       Date:  1979

7.  Cathepsin B activity in stimulated mouse peritoneal macrophages.

Authors:  B Mørland; A Pedersen
Journal:  Lab Invest       Date:  1979-11       Impact factor: 5.662

8.  The assessment of disease activity in rheumatoid arthritis using a multivariate analysis.

Authors:  R K Mallya; B E Mace
Journal:  Rheumatol Rehabil       Date:  1981-02-01

9.  Degradation of connective tissue matrices by macrophages. I. Proteolysis of elastin, glycoproteins, and collagen by proteinases isolated from macrophages.

Authors:  Z Werb; M J Banda; P A Jones
Journal:  J Exp Med       Date:  1980-11-01       Impact factor: 14.307

View more
  4 in total

1.  From the Large Scale Expression Analysis of Lupus Nephritis to Targeted Molecular Medicine.

Authors:  Celine C Berthier; Matthias Kretzler; Anne Davidson
Journal:  J Data Mining Genomics Proteomics       Date:  2012-03-27

2.  A serum antibody in patients with rheumatoid arthritis stimulates cathepsin B activity in peritoneal mouse macrophages.

Authors:  M Ostensen; B Mørland; G Husby; O P Rekvig
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

3.  Pregnancy and rheumatic disease. A review of recent studies in rheumatoid arthritis and ankylosing spondylitis.

Authors:  M Ostensen; G Husby
Journal:  Klin Wochenschr       Date:  1984-10-01

4.  The effect of normal and rheumatic pregnancy sera on intracellular cathepsin B activity in human monocytes.

Authors:  M Ostensen; G Husby; B Mørland
Journal:  Clin Exp Immunol       Date:  1986-02       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.